Is Echocardiography Missing Mild CTEPH Cases That May Benefit From Endarterectomy?
Pulmonary endarterectomy is an effective treatment for patients with chronic thromboembolic pulmonary hypertension.
Pulmonary endarterectomy is an effective treatment for patients with chronic thromboembolic pulmonary hypertension.
In patients with connective tissue disease-associated pulmonary arterial hypertension, selexipag may reduce risk for morbidity and mortality.
Anti-U1 ribonucleoprotein antibodies may increase chances of survival in patients with pulmonary arterial hypertension as a complication of systemic lupus erythematosus.
In patients undergoing percutaneous coronary intervention for either STEMI or NSTEMI, bivalirudin and heparin produce similar outcomes.
Supplemental oxygen therapy does not decrease the risk for 1-year all-cause mortality in patients with suspected myocardial infarction.
Coronary artery bypass grafting yielded better outcomes in patients with type 1 diabetes who had multivessel disease compared with percutaneous coronary intervention.
Despite more major bleeding events, rivaroxaban plus aspirin therapy had a greater cardiovascular benefit in patients with stable atherosclerotic vascular disease vs monotherapy.
In high-risk patients with atherosclerotic disease, canakinumab may help reduce the incidence of cardiovascular events.
Smoking, duration of diabetes, and male sex were among several independent predictors of silent coronary artery disease in patients with asymptomatic diabetes.